Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neurology|October 4, 2022
Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up StudySimone de Vries Lentsch, Britt W H van der Arend, Antoinette Maassen VanDenBrink, et al.
European Journal of Neurology|November 28, 2024
Switching from ligand to receptor anti-calcitonin gene-related peptide (CGRP) antibodies or vice versa in non-responders: A controlled cohort studyNancy van Veelen, Britt W H van der Arend, E Hiele, et al.
Trials|February 15, 2024
Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!)Britt W H van der Arend, Daphne S van Casteren, Iris E Verhagen, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 15, 2024
Practical Experience with the Use of Electronic Headache Diaries and Video Consultations in Migraine Care from a Longitudinal Cohort StudyBritt W H van der Arend, Linde J Holwerda, Iris E Verhagen, et al.
Cephalalgia : an International Journal of Headache|September 8, 2023
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort studyBritt W H van der Arend, Mirthe M Bloemhof, Alle G van der Schoor, et al.
Headache|March 21, 2023
Sex differences in migraine attack characteristics: A longitudinal E-diary studyIris E Verhagen, Britt W H van der Arend, Daphne S van Casteren, et al.
European Journal of Neurology|March 21, 2023
Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodiesIris E Verhagen, Simone de Vries Lentsch, Britt W H van der Arend, et al.
Neurology|September 8, 2021
Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-DiaryDaphne S van Casteren, Iris E Verhagen, Britt W H van der Arend, et al.
Frontiers in Neurology|May 14, 2024
Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraineBritt W H Van Der Arend, Nancy Van Veelen, Joëlle E T De Ruijter, et al.
European Journal of Neurology|October 17, 2023
Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraineSimone de Vries Lentsch, Britt W H van der Arend, Irene de Boer, et al.
Pageof 2